We are live on ! Find out more
AAP

Aristotle Atlantic Partners Portfolio holdings

AUM $2.14B
1-Year Est. Return 37.01%
This Fund
S&P 500
This Quarter Est. Return
+10.57%
1 Year Est. Return
+37.01%
3 Year Est. Return
+123.74%
5 Year Est. Return
+154.13%
10 Year Est. Return
–
AUM
$1.52B
AUM Growth
+$149M
Cap. Flow
+$21.3M
Cap. Flow %
1.41%
Top 10 Hldgs %
42.95%
Holding
104
New
3
Increased
64
Reduced
4
Closed
3

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$12.9M
2
SNOW icon
Snowflake
SNOW
+$10M
3
ADPT icon
Adaptive Biotechnologies
ADPT
+$5.7M
4
OGN icon
Organon & Co
OGN
+$1.9M
5
MSFT icon
Microsoft
MSFT
+$1.41M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$16.1M
2
AYX
Alteryx Inc
AYX
+$6.07M
3
QRVO icon
Qorvo
QRVO
+$3.5M
4
MRK icon
Merck
MRK
+$2.06M
5
GTLS
Chart Industries
GTLS
+$610K

Sector Composition

Rank Sector Weight
1 Technology 30.49%
2 Healthcare 20.63%
3 Consumer Discretionary 12.82%
4 Industrials 11.64%
5 Financials 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AWK icon
76
American Water Works
AWK
$26.3B
$2.37M 0.16%
15,391
+865
+6% +$135K
BMRN icon
77
BioMarin Pharmaceuticals
BMRN
$11.5B
$2.09M 0.14%
25,000
– –
BA icon
78
Boeing
BA
$165B
$1.8M 0.12%
7,500
– –
OGN icon
79
Organon & Co
OGN
$3.55B
$1.75M 0.12%
+57,821
New +$1.9M
SPGI icon
80
S&P Global
SPGI
$126B
$1.53M 0.1%
3,740
– –
GILD icon
81
Gilead Sciences
GILD
$161B
$1.46M 0.1%
21,200
– –
PG icon
82
Procter & Gamble
PG
$343B
$907K 0.06%
6,720
– –
KO icon
83
Coca-Cola
KO
$354B
$758K 0.05%
14,000
– –
WEC icon
84
WEC Energy
WEC
$37.7B
$706K 0.05%
7,941
– –
NOC icon
85
Northrop Grumman
NOC
$77B
$683K 0.05%
1,880
– –
LMT icon
86
Lockheed Martin
LMT
$134B
$568K 0.04%
1,500
– –
META icon
87
Meta Platforms (Facebook)
META
$1.51T
$514K 0.03%
1,478
+91
+7% +$29.2K
STZ icon
88
Constellation Brands
STZ
$22.2B
$449K 0.03%
1,920
+72
+4% +$16.9K
QCOM icon
89
Qualcomm
QCOM
$176B
$429K 0.03%
3,000
– –
PANW icon
90
Palo Alto Networks
PANW
$264B
$408K 0.03%
6,600
– –
GOOG icon
91
Alphabet (Google) Class C
GOOG
$3.9T
$383K 0.03%
3,060
+20
+0.7% +$2.38K
IIPR icon
92
Innovative Industrial Properties
IIPR
$1.78B
$382K 0.03%
2,000
– –
CRWD icon
93
CrowdStrike
CRWD
$187B
$376K 0.02%
5,988
+188
+3% +$10.1K
IBM icon
94
IBM
IBM
$202B
$352K 0.02%
2,510
– –
ERII icon
95
Energy Recovery
ERII
$434M
$342K 0.02%
15,000
– –
OKTA icon
96
Okta
OKTA
$24.1B
$333K 0.02%
1,359
+45
+3% +$10.9K
TDOC icon
97
Teladoc Health
TDOC
$1.58B
$333K 0.02%
2,000
– –
DOV icon
98
Dover
DOV
$27.2B
$301K 0.02%
2,000
– –
DHR icon
99
Danaher
DHR
$135B
$268K 0.02%
1,128
– –
JNJ icon
100
Johnson & Johnson
JNJ
$635B
$247K 0.02%
1,500
– –
1 2 3
4
5

Similar funds

SC
SouthState Corp Winter Haven, Florida $2.14B AUM 18.39% 1-Year Est. Return
EF
Empirical Finance Havertown, Pennsylvania $2.13B AUM 29.56% 1-Year Est. Return
NAAA
New Age Alpha Advisors Rye, New York $2.15B AUM 27.2% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
GHA
GW Henssler & Associates Kennesaw, Georgia $2.12B AUM 20.77% 1-Year Est. Return
BCM
Basswood Capital Management New York $2.12B AUM 19.53% 1-Year Est. Return
MA
Montag & Associates Atlanta, Georgia $2.15B AUM 20.86% 1-Year Est. Return
GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return

Aristotle Atlantic Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Aristotle Atlantic Partners held 104 positions worth $1.52B, up 11% from $1.37B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Aristotle Atlantic Partners's Q2 2021 filing shows 3 new, 64 increased, 4 reduced and 3 closed positions. Its largest new stake was Vertex Pharmaceuticals: 61,548 shares worth $12.4M. The largest sale was Cigna, an estimated $16.1M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Aristotle Atlantic Partners's largest Q2 2021 buy was Vertex Pharmaceuticals: 61,548 shares worth $12.4M.
  • Aristotle Atlantic Partners added most to Adaptive Biotechnologies in Q2 2021, an estimated $5.7M increase.
  • Aristotle Atlantic Partners's biggest Q2 2021 reduction was Cigna, cutting an estimated $16.1M.
  • Aristotle Atlantic Partners fully exited Alteryx Inc in Q2 2021, selling an estimated $6.07M.
  • Aristotle Atlantic Partners's ten largest holdings make up 43% of its $1.52B portfolio in Q2 2021.
  • Aristotle Atlantic Partners opened 3 new positions and closed 3 in Q2 2021.
  • Aristotle Atlantic Partners's portfolio value rose 11% quarter-over-quarter to $1.52B.

Based on Aristotle Atlantic Partners's 13F filing for Q2 2021, filed 16 Aug 2021.